Strategy and Business Planning For ATMP Companies
After your initial brainstorm, it is time to bring all your thoughts together in a coherent business plan. In this topic Ingrid Maes guides you through the various building blocks of such a plan and explains the different aspects of the commercial, financial and implementation strategy. In addition, she emphasizes the importance of parallel planning for product & process development, clinical development and market access and how these different schedules have an impact on your business strategy.
The Speaker
Ingrid Maes
Ingrid Maes is co-Founder and Managing Director at Inovigate, based in Antwerp (B) and Basel (CH). Ingrid has 30+ years of experience in the life science sector, in management consulting, in international leadership roles and in international companies (PwC, Siemens and Alf-Laval). She is an expert in market access with a focus on sector insight and foresight, market analysis, business planning and strategy formulation. Ingrid has a Master in Engineering Sciences – Chemistry & Biotechnology from the University of Brussels.
The Company
Inovigate
Inovigate is an independent strategy and management consulting company operating in the European Life Science and Healthcare industry, specialised in helping clients to innovate and navigate through an increasingly complex health ecosystem.